Chiesi, an international, research-driven biopharmaceutical group, develops and markets innovative medicinal and non-medicinal solutions. Chiesi distinguishes between three business areas: AIR, products and services related to respiratory diseases. The Air area also includes self-medication products, such as pharmacy-only medicines and cosmetics; RARE, the treatment of patients with rare and very rare diseases; and CARE, medicines for transplant recipients. 

The company’s purpose is to improve people’s quality of life while acting responsibly towards society and the environment. Through the change of its legal status to a Benefit Corporation in the countries where this is possible (Italy, the USA, France and Colombia), Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to decision-making across the company. Chiesi has been B Corp certified since 2019. This certification ensures that Chiesi’s sustainable corporate governance is measured, assessed and continuously improved according to independent global standards. The company aims to achieve net-zero emissions by 2035 (Scopes 1-3). Efforts towards this target are communicated transparently via the website https://actionoverwords.org/de/ and in our sustainability report. 

With 90 years of experience, Chiesi is headquartered in Parma, Italy, and operates in 31 countries with more than 7,900 employees. In 2025, the company generated revenue of EUR 3.625 billion, of which 24.4% (EUR 885 million) was reinvested in research and development. The Group’s research and development centre is based in Parma. In addition, the Group operates six further R&D centres in France, the USA, Canada, China, the United Kingdom and Sweden. Further information is available here: www.chiesi.com 

Chiesi GmbH in Germany 

Chiesi GmbH, based in Hamburg, employs around 420 people across Germany. As one of the largest affiliates of the Chiesi Group, it generated revenue of EUR 369.9 million in 2025. In 2025, the medium-sized company was recognised as a Top Employer by the Top Employers Institute for the fourteenth consecutive time, and in 2020 it also received the “Great Place to Work” certification for the first time. 

-